Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with… Feb 17, 2022
Group Therapy Plays Important Role In New Study On Psilocybin For Depression In Cancer Patients Feb 15, 2022
HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S. Market Feb 10, 2022
Therapsil CEO Spencer Hawkswell Speaks To Health Canada’s Intent To Deny Section 56 Exemptions To Healthcare… Feb 9, 2022
Mydecine’s Exclusive Dealer Identified as Licensed Psilocybin and MDMA Supplier in Canada Feb 8, 2022
